Dane Bedward is the Chairman of the Board of Directors at Spiderwort Inc. and serves as CEO of NBot Inc, a global commercialization advisory group specializing in biopharmaceutical and medical device product categories. They have held key positions, including Vice President and General Manager of Genzyme Americas and created Genzyme Canada, which successfully launched the product Cerezyme. Dane is currently a member of the Board of Directors at Capital BioVentures and has extensive experience as a principal at NeuroBot Inc and an executive fellow at Mistral Venture Partners. They hold an Honors Bachelor of Science in Biology from the University of Ottawa.
This person is not in the org chart
This person is not in any teams
This person is not in any offices